Property Summary

NCBI Gene PubMed Count 39
PubMed Score 375.90
PubTator Score 560.56

Knowledge Summary


No data available


  Differential Expression (18)

Disease log2 FC p
Multiple myeloma 1.730 9.0e-04
malignant mesothelioma -2.200 9.7e-08
psoriasis 1.700 9.1e-04
osteosarcoma 2.076 2.0e-05
astrocytoma 1.100 3.7e-02
medulloblastoma, large-cell -1.100 2.3e-02
Atopic dermatitis -1.100 1.2e-03
pancreatic ductal adenocarcinoma liver m... 1.259 8.3e-03
intraductal papillary-mucinous carcinoma... -1.500 1.1e-02
active Crohn's disease 1.347 4.7e-02
breast carcinoma -1.100 7.2e-05
group 4 medulloblastoma -1.900 3.6e-05
pilocytic astrocytoma 1.100 1.5e-07
subependymal giant cell astrocytoma 1.789 8.5e-03
lung carcinoma 2.700 1.4e-34
invasive ductal carcinoma -2.000 1.8e-04
ulcerative colitis 1.800 1.3e-05
ovarian cancer -1.500 9.7e-04

Gene RIF (9)

26982589 Data suggest that His108 and a substrate molecule are involved in the reductive pathway while His172 and Tyr79 are important in the catalytic pathway in the copper-centered electron transfer catalyzed by peptidylglycine monooxygenase.
26879543 PAM expression is increased in the secretory pathway of differentiated neurons.
26296884 Oxygen Sensitivity of the Peptidylglycine alpha-Amidating Monooxygenase (PAM) in Neuroendocrine Cells
24464100 Two missense variants in PAM, encoding p.Asp563Gly (frequency of 4.98%) and p.Ser539Trp (frequency of 0.65%), confer moderately higher risk of type 2 diabetes (OR = 1.23, P = 3.9 x 10(-10) and OR = 1.47, P = 1.7 x 10(-5), respectively)
22554821 Detail the production of the catalytic core of human peptidylglycine alpha-hydroxylating monooxygenase (hPHMcc) in Escherichia coli possessing a N-terminal fusion to thioredoxin (Trx).
22080626 Data indicate that catalytic inactivation of PHM caused by pH changes is accompanied by structural change between two states of the protein involving strong Cu-S interaction that does not involve M314.
20379614 Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)
20351714 Observational study of gene-disease association. (HuGE Navigator)
16107699 nuclear retention of PAM mRNA is lost upon expressing the La proteins that lack a conserved nuclear retention element, suggesting a direct association between PAM mRNA and La protein in vivo

AA Sequence


Text Mined References (45)

PMID Year Title
26982589 2016 Stopped-Flow Studies of the Reduction of the Copper Centers Suggest a Bifurcated Electron Transfer Pathway in Peptidylglycine Monooxygenase.
26879543 2016 Neuronal differentiation is associated with a redox-regulated increase of copper flow to the secretory pathway.
26296884 2015 Striking Oxygen Sensitivity of the Peptidylglycine ?-Amidating Monooxygenase (PAM) in Neuroendocrine Cells.
24464100 2014 Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes.
23533145 2013 In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
23376485 2013 Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
23186163 2013 Toward a comprehensive characterization of a human cancer cell phosphoproteome.
22554821 2012 Production of the catalytic core of human peptidylglycine ?-hydroxylating monooxygenase (hPHMcc) in Escherichia coli.
22080626 2011 A copper-methionine interaction controls the pH-dependent activation of peptidylglycine monooxygenase.
21406692 2011 System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
20379614 Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
20351714 2011 Poor replication of candidate genes for major depressive disorder using genome-wide association data.
19946888 2010 Defining the membrane proteome of NK cells.
19693765 2009 The peptidylglycine alpha-amidating monooxygenase (PAM): a novel prodrug strategy for amidoximes and N-hydroxyguanidines?
19571808 2009 Common variants conferring risk of schizophrenia.
19199708 2009 Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
18669648 2008 A quantitative atlas of mitotic phosphorylation.
17081983 2006 Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
16344560 2006 Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.
16107699 2005 Mammalian peptidylglycine alpha-amidating monooxygenase mRNA expression can be modulated by the La autoantigen.
15489334 2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
15372022 2004 The DNA sequence and comparative analysis of human chromosome 5.
14702039 2004 Complete sequencing and characterization of 21,243 full-length human cDNAs.
12699694 2003 Expression and characterization of human bifunctional peptidylglycine alpha-amidating monooxygenase.
12477932 2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
12364573 2002 Immunocytochemical finding of the amidating enzymes in mouse pancreatic A-, B-, and D-cells: a comparison with human and rat.
11668475 2001 Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate.
10574929 1999 The novel kinase peptidylglycine alpha-amidating monooxygenase cytosolic interactor protein 2 interacts with the cytosolic routing determinants of the peptide processing enzyme peptidylglycine alpha-amidating monooxygenase.
9562574 1998 Peptide-amidating enzymes are expressed in the stellate epithelial cells of the thymic medulla.
9110174 1997 Large-scale concatenation cDNA sequencing.
8619474 1996 A "double adaptor" method for improved shotgun library construction.
8543779 1996 Distribution of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in normal human lung and in lung epithelial tumors.
8530412 1995 Phosphorylation of the cytosolic domain of peptidylglycine alpha-amidating monooxygenase.
8518727 1993 Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains.
8486658 1993 Use of endoproteases to identify catalytic domains, linker regions, and functional interactions in soluble peptidylglycine alpha-amidating monooxygenase.
8288234 1993 Localization of the gene encoding peptidylglycine alpha-amidating monooxygenase (PAM) to human chromosome 5q14-5q21.
8144680 1994 Alternative splicing governs sulfation of tyrosine or oligosaccharide on peptidylglycine alpha-amidating monooxygenase.
8102327 1993 Peptide alpha-amidation activity in human plasma: relationship to gastrin processing.
8094086 1993 Immunocytochemical localization of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in human endocrine pancreas.
7999037 1994 Isolation and functional expression of human pancreatic peptidylglycine alpha-amidating monooxygenase.
7760848 1995 The NH2-terminal proregion of peptidylglycine alpha-amidating monooxygenase facilitates the secretion of soluble proteins.
7606087 1995 Increased peptidylglycine alpha-amidating monooxygenase activity in cerebrospinal fluid of patients with multiple sclerosis.
7590286 1995 Human peptidylglycine alpha-amidating monooxygenase transcripts derived by alternative mRNA splicing of an unreported exon.
2357221 1990 Human peptidylglycine alpha-amidating monooxygenase: cDNA, cloning and functional expression of a truncated form in COS cells.
1448112 1992 The multifunctional peptidylglycine alpha-amidating monooxygenase gene: exon/intron organization of catalytic, processing, and routing domains.